This book comprehensively covers the mechanisms of action and inhibitor design for HIV-1 integrase. It serves as a resource for scientists facing challenging drug design issues and researchers in antiviral drug discovery. Despite numerous review articles and isolated book chapters dealing with HIV-1 integrase, there has not been a single source for those working to devise anti-AIDS drugs against this promising target. But this book fills that gap and offers a valuable introduction to the field for the interdisciplinary scientists who will need to work together to design drugs that target HIV-1 integrase.
Об авторе
Nouri Neamati, Ph D, is an Associate Professor of Pharmacology
and Pharmaceutical Sciences at the University of Southern
California School of Pharmacy. He is the recipient of numerous
awards and has published more than 170 peer-reviewed manuscripts,
several book chapters, and patents in the area of drug design and
discovery. Dr. Neamati is the Editor-in-Chief of Current Molecular
Pharmacology; an Associate Editor of Current Cancer Drug Targets;
and an Editorial Advisory Board member of several journals
including Expert Opinion on Drug Discovery, Expert Opinion on
Investigational Drugs, and Hormones & Cancer.
Больше книг от того же автора (ов) / редактор
27 805 Электронные книги в этой категории
